Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma

26 Mar 2019

Abstract excerpt

Neuroblastoma (NB) is a commonly occurring cancer among infants and young children. Recently, long non-coding RNAs (lncRNAs) have been using as prognostic biomarkers for therapeutics and interventions in various cancers. Considering the poor survival of NB, the lncRNA-based therapeutic strategies must be improved. This work proposes an overall survival time estimator called SVR-NB to identify the lncRNA signature...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to interferon and immune responses
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30914706
DOI: 10.1038/s41598-019-41553-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastomaPMID 30914706Read ↗

Development and Validation of a Lncrnas-Based Nomogram for Survival Prediction in Neuroblastoma PatientsSemantic proximity Read ↗

High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in NeuroblastomaSemantic proximity Read ↗

Bioinformatics Analysis Combined with Experiments to Explore Neuroblastoma Prognostic Indicators Based on Immune-related Genes.Semantic proximity Read ↗

Clinically Relevant Biomarker Discovery in High-Risk Recurrent NeuroblastomaSemantic proximity Read ↗

Bioinformatics identification of key genes associated with risk and prognosis of neuroblastomaSemantic proximity Read ↗

Integrated Analysis of Immune-Related Genes in High-Risk NeuroblastomaSemantic proximity Read ↗

A Novel Prognostic Model Predicts Overall Survival in Patients With Nasopharyngeal Carcinoma Based on Clinical Features and Blood BiomarkersSemantic proximity Read ↗

Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profilesSemantic proximity Read ↗

A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkersSemantic proximity Read ↗

Precision survival estimation in acute myeloid leukemia using evolutionary learning-derived microRNA signatureSemantic proximity Read ↗

A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkersSemantic proximity Read ↗

Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients’ survival timeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.